UB Paderborn / Katalog / Suche / in CDI

Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians

Journal of thrombosis and haemostasis, 2018-02, Vol.16 (2), p.209-219

2018

Volltextzugriff (PDF)

Pre-analytical issues in the haemostasis laboratory: guidance for the clinical laboratories

Thrombosis journal, 2016-12, Vol.14 (1), p.49-49, Article 49

2016

Volltextzugriff (PDF)

Don't let D-dimer fool you: Elevated D-dimer plasma levels should not imply ‘hyperfibrinolysis’

Thrombosis research, 2022-06, Vol.214, p.63-64

2022

Volltextzugriff (PDF)

Comparison of calibrated dilute thrombin time and aPTT tests with LC-MS/MS for the therapeutic monitoring of patients treated with dabigatran etexilate

Thrombosis and haemostasis, 2013-09, Vol.110 (3), p.543

2013

Volltextzugriff (PDF)

Management of the thrombotic risk associated with COVID-19: guidance for the hemostasis laboratory

Thrombosis journal, 2020-09, Vol.18 (1), p.17-16, Article 17

2020

Volltextzugriff (PDF)

Clotting test results correlate better with DOAC concentrations when expressed as a “Correction Ratio”; results before/after extraction with the DOAC Stop reagent

Thrombosis research, 2019-07, Vol.179, p.69-72

2019

Volltextzugriff (PDF)

Serial fibrin monomer and D-dimer plasma levels measurements can capture thrombotic complications in critically ill COVID-19 patients: A prospective observational study

Thrombosis research, 2023-01, Vol.221, p.69-72

2023

Volltextzugriff (PDF)

Diagnosis and management of congenital thrombophilia in the era of direct oral anticoagulants

Thrombosis research, 2020-01, Vol.185, p.72-77

2020

Volltextzugriff (PDF)

Heparin‐induced multi‐electrode aggregometry method for heparin‐induced thrombocytopenia testing: communication from the SSC of the ISTH

Journal of thrombosis and haemostasis, 2016-12, Vol.14 (12), p.2548-2552

2016

Volltextzugriff (PDF)

Investigations for fetal and neonatal alloimmune thrombocytopenia: communication from the SSC of the ISTH

Journal of thrombosis and haemostasis, 2018-12, Vol.16 (12), p.2526-2529

2018

Volltextzugriff (PDF)

Platelet microparticle generation assay: A valuable test for immune heparin-induced thrombocytopenia diagnosis

Thrombosis research, 2014-06, Vol.133 (6), p.1068-1073

2014

Volltextzugriff (PDF)

Pre‐analytical issues in the measurement of circulating microparticles: current recommendations and pending questions

Journal of thrombosis and haemostasis, 2013-04, Vol.11 (4), p.693-696

2013

Volltextzugriff (PDF)

More on: calibration for the measurement of microparticles: needs, interests, and limitations of calibrated polystyrene beads for flow cytometry‐based quantification of biological microparticles

Journal of thrombosis and haemostasis, 2011-08, Vol.9 (8), p.1679-1681

2011

Volltextzugriff (PDF)

Analytical and clinical evaluation of four commercial SARS-CoV-2 serological immunoassays in hospitalized patients and ambulatory individuals

Journal of virological methods, 2021-03, Vol.289, p.114060-114060, Article 114060

2021

Volltextzugriff (PDF)

Rapid exclusion of the diagnosis of immune HIT by AcuStar HIT and heparin-induced multiple electrode aggregometry

Thrombosis research, 2014-06, Vol.133 (6), p.1074-1078

2014

Volltextzugriff (PDF)

Andexanet alfa for the reversal of factor Xa inhibitors

Expert opinion on biological therapy, 2019-05, Vol.19 (5), p.387-397

2019

Volltextzugriff (PDF)

D-dimer testing: A narrative review

Advances in clinical chemistry, 2023, Vol.114, p.151-223

2023

Volltextzugriff (PDF)

Influence of apixaban on commonly used coagulation assays: results from the Belgian national External Quality Assessment Scheme

International journal of laboratory hematology, 2017-08, Vol.39 (4), p.402-408

2017

Volltextzugriff (PDF)

Reduction of the turn‐around time for the measurement of rivaroxaban and apixaban: Assessment of the performance of a rapid centrifugation method

International journal of laboratory hematology, 2018-12, Vol.40 (6), p.e105-e108

2018

Volltextzugriff (PDF)

Real‐world variability in dabigatran levels in patients with atrial fibrillation: comment

Journal of thrombosis and haemostasis, 2015-06, Vol.13 (6), p.1166-1168

2015

Volltextzugriff (PDF)

Assessment of the performances of AcuStar HIT and the combination with heparin-induced multiple electrode aggregometry: A retrospective study

Thrombosis research, 2013-09, Vol.132 (3), p.352-359

2013

Volltextzugriff (PDF)

A reminder of the place of morphology and the H‐score in the diagnosis of hemophagocytic lymphohistiocytosis (HLH)

Clinical case reports, 2018-03, Vol.6 (3), p.527-528

2018

Volltextzugriff (PDF)

Impact of apixaban on routine and specific coagulation assays: a practical laboratory guide

Thrombosis and haemostasis, 2013-08, Vol.110 (2), p.283

2013

Volltextzugriff (PDF)

Comparison of calibrated chromogenic anti-Xa assay and PT tests with LC-MS/MS for the therapeutic monitoring of patients treated with rivaroxaban

Thrombosis and haemostasis, 2013-10, Vol.110 (4), p.723

2013

Volltextzugriff (PDF)

Bioactivity and hemocompatibility study of amorphous hydrogenated carbon coatings produced by pulsed magnetron discharge

Journal of biomedical materials research. Part A, 2013-06, Vol.101A (6), p.1800-1812

2013

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians

Pre-analytical issues in the haemostasis laboratory: guidance for the clinical laboratories

Don't let D-dimer fool you: Elevated D-dimer plasma levels should not imply ‘hyperfibrinolysis’

Comparison of calibrated dilute thrombin time and aPTT tests with LC-MS/MS for the therapeutic monitoring of patients treated with dabigatran etexilate

Management of the thrombotic risk associated with COVID-19: guidance for the hemostasis laboratory

Clotting test results correlate better with DOAC concentrations when expressed as a “Correction Ratio”; results before/after extraction with the DOAC Stop reagent

Serial fibrin monomer and D-dimer plasma levels measurements can capture thrombotic complications in critically ill COVID-19 patients: A prospective observational study

Diagnosis and management of congenital thrombophilia in the era of direct oral anticoagulants

Heparin‐induced multi‐electrode aggregometry method for heparin‐induced thrombocytopenia testing: communication from the SSC of the ISTH

Investigations for fetal and neonatal alloimmune thrombocytopenia: communication from the SSC of the ISTH

Platelet microparticle generation assay: A valuable test for immune heparin-induced thrombocytopenia diagnosis

Pre‐analytical issues in the measurement of circulating microparticles: current recommendations and pending questions

More on: calibration for the measurement of microparticles: needs, interests, and limitations of calibrated polystyrene beads for flow cytometry‐based quantification of biological microparticles

Analytical and clinical evaluation of four commercial SARS-CoV-2 serological immunoassays in hospitalized patients and ambulatory individuals

Rapid exclusion of the diagnosis of immune HIT by AcuStar HIT and heparin-induced multiple electrode aggregometry

Andexanet alfa for the reversal of factor Xa inhibitors

D-dimer testing: A narrative review

Influence of apixaban on commonly used coagulation assays: results from the Belgian national External Quality Assessment Scheme

Reduction of the turn‐around time for the measurement of rivaroxaban and apixaban: Assessment of the performance of a rapid centrifugation method

Real‐world variability in dabigatran levels in patients with atrial fibrillation: comment

Assessment of the performances of AcuStar HIT and the combination with heparin-induced multiple electrode aggregometry: A retrospective study

A reminder of the place of morphology and the H‐score in the diagnosis of hemophagocytic lymphohistiocytosis (HLH)

Impact of apixaban on routine and specific coagulation assays: a practical laboratory guide

Comparison of calibrated chromogenic anti-Xa assay and PT tests with LC-MS/MS for the therapeutic monitoring of patients treated with rivaroxaban

Bioactivity and hemocompatibility study of amorphous hydrogenated carbon coatings produced by pulsed magnetron discharge

Suchergebnisse filtern